In this issue:
Alemtuzumab for refractory metastatic HS
Bone marrow vs. peripheral blood for AAA SCTs
All-trans-retinoic acid, idarubicin and arsenic trioxide in APML
VTD as induction pretransplant therapy in MM
Treating older MCL patients
Bortezomib induction and maint
Please login below to download this issue (PDF)